The aim of our study was to investigate the application of contrast-enhanced ultrasound
(CEUS) and its quantification analysis for the prediction of early treatment response of …

Objectives To compare the accuracy of contrast-enhanced ultrasound (CEUS) and Dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) for the assessment of …

Purpose The aim of this study was to assess the early response to sorafenib using
ultrasound molecular imaging in a murine model of hepatocellular carcinoma (HCC) …

Purpose To assess therapeutic response monitoring after targeted therapy in an orthotopic
rat model of hepatocellular carcinoma (HCC) using CEUS with focusing on inter-scanner …

Purpose: Sorafenib is the reference therapy for advanced hepatocellular carcinoma (HCC).
There is no method for predicting in the early period subsequent individual response …

The aim of this study was to assess the feasibility of using dynamic contrast-enhanced
ultrasound (DCE-US) with a 3-D transducer to evaluate therapeutic responses to targeted …

AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …

The present study aimed to determine the usefulness of contrast-enhanced ultrasonography
(CEUS) with Sonazoid in evaluating the therapeutic response to sorafenib for hepatocellular …

Aim: The aim of this study was to compare vascularity observed using contrast-enhanced 3D
ultrasonography and pathological changes in human hepatocellular carcinoma (HCC) and …

AIM: To verify whether arterial-phase contrast-enhanced ultrasonography (CEUS) of tumor
parenchymal tissue is useful for evaluation of anti-angiogenesis agents. METHODS: Rabbits …